Beremagene geperpavec for treating skin wounds associated with dystrophic epidermolysis bullosa [ID3959]
In development
Reference number: GID-TA10868
Expected publication date:
Following a routing challenge raised by the company, regarding the Topic Selection Oversight Panel (TSOP) decision to route Beremagene Geperpavec as a Technology Appraisal, the start of this evaluation is delayed. The timelines for the evaluation will be confirmed once TSOP have reviewed the challenge.